Literature DB >> 6340475

Gonadal injury resulting from chemotherapy.

R M Chapman.   

Abstract

Radiation, alkylating agents and the vinca alkaloids produce variable degrees of gonadal dysfunction in humans; additional drugs have been linked to gonadal damage in males only. Age at time of exposure and total dose of drug administered are associated with the degree of gonadal injury. Irreversible sterility develops at lower doses in men than in women. The infertile men usually retain sexual function, whereas the infertile women experience premature menopause and sexual dysfunction. Subfertility with normal sexual function is the sequela of lesser degrees of gonadal injury in men and women. For a given drug dose, children apparently sustain less gonadal damage than their adult counterparts. Rigorous reporting of basic essential data will enhance our understanding of drug-induced gonadal damage; incomplete reports only cloud the issue.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6340475

Source DB:  PubMed          Journal:  Am J Ind Med        ISSN: 0271-3586            Impact factor:   2.214


  12 in total

Review 1.  Ovarian metabolism of xenobiotics.

Authors:  Poulomi Bhattacharya; Aileen F Keating
Journal:  Exp Biol Med (Maywood)       Date:  2011-05-26

Review 2.  4-vinylcyclohexene diepoxide: a model chemical for ovotoxicity.

Authors:  Connie J Kappeler; Patricia B Hoyer
Journal:  Syst Biol Reprod Med       Date:  2012-02       Impact factor: 3.061

3.  Gonadal function after allogenic bone marrow transplantation for thalassaemia.

Authors:  V De Sanctis; M Galimberti; G Lucarelli; P Polchi; L Ruggiero; C Vullo
Journal:  Arch Dis Child       Date:  1991-04       Impact factor: 3.791

Review 4.  Treatment of systemic lupus erythematosus: which options do we have for therapy regimens?

Authors:  L Kater; R H Derksen; R J Hené
Journal:  Rheumatol Int       Date:  1991       Impact factor: 2.631

5.  Differential susceptibility of immature rat testes to doxorubicin at critical stages of maturation. Biochemical and functional assessment.

Authors:  R Bechter; R Haebler; R A Ettlin; J K Haseman; R L Dixon
Journal:  Arch Toxicol       Date:  1987-08       Impact factor: 5.153

6.  Familial premature ovarian failure.

Authors:  D R Mattison; M I Evans; W B Schwimmer; B J White; B Jensen; J D Schulman
Journal:  Am J Hum Genet       Date:  1984-11       Impact factor: 11.025

7.  Pubertal development in thalassaemic patients after allogenic bone marrow transplantation.

Authors:  V De Sanctis; M Galimberti; G Lucarelli; E Angelucci; M Ughi; D Baronciani; P Polchi; C Giardini; B Bagni; C Vullo
Journal:  Eur J Pediatr       Date:  1993-12       Impact factor: 3.183

8.  Interagency regulatory liaison group workshop on reproductive toxicity risk assessment.

Authors:  C A Kimmel; G L Kimmel; V Frankos
Journal:  Environ Health Perspect       Date:  1986-04       Impact factor: 9.031

Review 9.  Selection of reproductive health end points for environmental risk assessment.

Authors:  D A Savitz; S D Harlow
Journal:  Environ Health Perspect       Date:  1991-01       Impact factor: 9.031

10.  Protective effects of ethyl pyruvate on sperm quality in cyclophosphamide treated mice.

Authors:  Zahra Bakhtiary; Rasoul Shahrooz; Abbas Ahmadi; Leila Zarei
Journal:  Iran J Reprod Med       Date:  2015-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.